The final chapter in genomic medicine
Tome Biosciences is the programmable gene insertion company. Using CRISPR, our technologies allow us to insert any genetic sequence of any size at any location into any genome. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and genome engineering.
Join us and be part of the future of genomic medicines firstname.lastname@example.org. Open positions:
Tome Biosciences |One Kendall Square | Building 200, Suite 001 |Cambridge, MA 02139 |email@example.com